Trial Profile
A pivotal, randomized, cross-over, comparative pharmacokinetic study comparing ZTlido (lidocaine patch 1.8%) with Versatis (lidocaine medicated plaster 5%) in healthy subjects.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary) ; Lidocaine (Primary)
- Indications Postherpetic neuralgia
- Focus Pharmacokinetics
- 07 Sep 2018 According to a Scilex Pharmaceuticals media release, data from this trial presented at PAINWeek 2018
- 28 Feb 2018 Results presented in a Sorrento Therapeutics Media Release.
- 05 Feb 2018 According to a Scilex Pharmaceuticals media release, MAA decision for ZTlido topical lidocaine system in the Europe is anticipated by year end 2018.